Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Cisio De Oliveira Brandao
Clinical Effectiveness and Safety of Erythropoietin‐stimulating Agents for the Treatment of Low‐ and Intermediate‐1−risk Myelodysplastic Syndrome: A Systematic Literature Review
British Journal of Haematology
Hematology
Related publications
Systematic Literature Review of Treatment Options and Clinical Outcomes for Patients With Higher Risk Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
Treatment of Anemia in Low Risk Myelodysplastic Syndromes With Granulocyte–macrophage Colony-Stimulating Factor Plus Recombinant Human Erythropoietin
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Systematic Review: Treatment Pattern and Clinical Effectiveness and Safety of Pharmaceutical Therapies for Crohn’s Disease in Europe
Clinical and Experimental Gastroenterology
Gastroenterology
Clinical Effectiveness and Cost-Effectiveness of Interventions for the Treatment of Anogenital Warts: Systematic Review and Economic Evaluation
Health Technology Assessment
Medicine
Health Policy
Effectiveness and Safety of Therapeutic Regimens for Elderly Patients With Acute Myeloid Leukemia: A Systematic Literature Review
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
A Review of Erythropoietin Abuse: An Analysis of Effectiveness and Safety in Exercise
Journal of Sports Medicine & Doping Studies
Correction To: The Prognostic Value of Serum Erythropoietin in Patients With Lower-Risk Myelodysplastic Syndromes: A Review of the Literature and Expert Opinion
Annals of Hematology
Medicine
Hematology
Clinical Efficacy of Chelation Therapy in Patients With Low-Risk Myelodysplastic Syndrome
Klinicheskaya Onkogematologiya/Clinical Oncohematology
Oncology
Hematology
A Systematic Review of the Clinical Effectiveness and Cost-Effectiveness of Pharmalgen® for the Treatment of Bee and Wasp Venom Allergy.
Health Technology Assessment
Medicine
Health Policy
